CVS Health Corporation provided earnings guidance for the year 2023. For 2023, the company expects EPS at the upper end of previously indicated range of $8.50 to $8.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.52 USD | -1.08% | -6.82% | -27.15% |
06-27 | Walgreens cuts 2024 profit forecast, announces store closures | RE |
06-27 | Walgreens cuts 2024 profit forecast on worse-than-expected consumer spending | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.15% | 73B | |
+18.11% | 82.53B | |
-1.13% | 26.4B | |
-10.81% | 17.12B | |
+1.21% | 17.09B | |
-0.90% | 15.23B | |
+76.72% | 13.24B | |
+77.64% | 13.02B | |
-25.09% | 12.82B | |
+21.18% | 12.19B |
- Stock Market
- Equities
- CVS Stock
- News CVS Health Corporation
- CVS Health Corporation Provides Earnings Guidance for the Year 2023